Life Sciences Regulation To Watch In 2018
Although prescription drug pricing and opioid abuse have held prominent positions in public discourse over the past year, experts say the future is uncertain for legislation and regulation in those areas...To view the full article, register now.
Already a subscriber? Click here to view full article